Comorbidities
Conditions
Keywords
Rehabilitation patients, wireless monitoring, vital signs
Brief summary
Some patients unable to return home from hospital due to physical or mental illness will be discharged to a rehabilitation home to restore strength and rehabilitate. This study attempts to examine if it is possible to continuously monitor the vital signs in patients discharged to a rehabilitation center and whether wearable devices will detect more abnormal vital signs than the rehabilitation facility, as well as complication and readmission rates.
Detailed description
Patients who are ready to leave the hospital but are deemed unable to return home are discharged to a rehabilitation center to regain strength and performance. Vital signs are only measured when deemed necessary at the rehabilitation center, in contrast to hospital wards, where vital signs are measured intermittently and manually every 8-12 hours. Wearable devices that continuously monitor a patient's vital signs may be able to detect patients who are deteriorating, as abnormal vital signs often precede a physiologic decline This study aims to determine whether it is possible to continuously monitor patients discharged to a rehabilitation center and detect more abnormal vital signs than measurements from the rehabilitation center. By attaching three wearable devices to 20 patients, we wished to record the vital signs for up to 96 hours, documenting abnormal vital signs as well as complications - and readmission rates.
Interventions
None listed
Sponsors
Rigshospitalet, Denmark
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
No
Inclusion criteria
* discharged to the rehabilitation center after surgery or; diagnosed with ischemic heart disease, chronic heart disease, apoplexia cerebri, chronic obstructive pulmonary disease, or diabetes. * Inclusion less than 72 h from rehabilitation admission
Exclusion criteria
* Unable to give informed consent * Implanted pacemaker or cardioverter-defibrillator * allergic to plaster, plastic, silicone
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Monitoring time | 96 hours | Monitoring time with data from any device |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| SpO2 < 92% | 96 hours | Duration of SpO2 \< 92% |
| SpO2 < 88% | 96 hours | Duration of SpO2 \< 88% |
| SpO2 < 85% | 96 hours | Duration of SpO2 \< 85% |
| SpO2 < 80% | 96 hours | Duration of SpO2 \< 80% |
| Respiratory rate <5 breaths per minute | 96 hours | Duration of respiratory rate \<5 breaths per minute |
| Respiratory rate <11 breaths per minute | 96 hours | Duration of respiratory rate \<11 breaths per minute |
| Respiratory rate >24 breaths per minute | 96 hours | Duration of respiratory rate \>24 breaths per minute |
| Respiratory rate >30 breaths per minute | 96 hours | Duration of respiratory rate \>30 breaths per minute |
| Systolic blood pressure >180 mmHg | 96 hours | Number of systolic blood pressure \>180 mmHg measurements |
| Systolic blood pressure >220 mmHg | 96 hours | Number of systolic blood pressure \>220 mmHg measurements |
| Heart rate <30 beats per minute | 96 hours | Duration of heart rate \<30 beats per minute |
| Heart rate <40 beats per minute | 96 hours | Duration of heart rate \<40 beats per minute |
| Heart rate > 110 beats per minute | 96 hours | Duration of heart rate \> 110 beats per minute |
| Heart rate > 130 beats per minute | 96 hours | Duration of heart rate \> 130 beats per minute |
| Systolic blood pressure <70 mmHg | 96 hours | Number of systolic blood pressure \<70 mmHg measurements |
| Systolic blood pressure <90 mmHg | 96 hours | Number of systolic blood pressure \<90 mmHg measurements |
Other
| Measure | Time frame | Description |
|---|---|---|
| Complication | 30 days | Complication frequency within 30 days from study inclusion |
| Readmission | 30 days | Readmission frequency within 30 days from study inclusion |
Countries
Denmark
Outcome results
None listed